{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:41:26Z","timestamp":1770705686743,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T00:00:00Z","timestamp":1514592000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00210-017-1459-z","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T18:15:01Z","timestamp":1514571301000},"page":"309-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Modulation of the IL-23\/IL-17 axis by fenofibrate ameliorates the ovalbumin\/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats"],"prefix":"10.1007","volume":"391","author":[{"given":"Samah M.","family":"Elaidy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha S.","family":"Essawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona A.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.","family":"El-Kherbetawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman R.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,30]]},"reference":[{"key":"1459_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jep.2016.07.082","volume":"197","author":"P Arora","year":"2017","unstructured":"Arora P, Ansari SH, Anjum V, Mathur R, Ahmad S (2017) Investigation of anti-asthmatic potential of Kanakasava in ovalbumin-induced bronchial asthma and airway inflammation in rats. J Ethnopharmacol 197:242\u2013249. \nhttps:\/\/doi.org\/10.1016\/j.jep.2016.07.082","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1459_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-065X.2011.01020.x","volume":"242","author":"PJ Barnes","year":"2011","unstructured":"Barnes PJ (2011) Pathophysiology of allergic inflammation. Immunol Rev 242(1):31\u201350. \nhttps:\/\/doi.org\/10.1111\/j.1600-065X.2011.01020.x","journal-title":"Immunol Rev"},{"issue":"2","key":"1459_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pupt.2007.08.001","volume":"21","author":"J Becker","year":"2008","unstructured":"Becker J, Delayre-Orthez C, Frossard N, Pons F (2008) Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation. Pulm Pharmacol Ther 21(2):324\u2013330. \nhttps:\/\/doi.org\/10.1016\/j.pupt.2007.08.001","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"1459_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1472-8206.2006.00425.x","volume":"20","author":"J Becker","year":"2006","unstructured":"Becker J, Delayre-Orthez C, Frossard N, Pons F (2006) Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundam Clin Pharmacol 20(5):429\u2013447. \nhttps:\/\/doi.org\/10.1111\/j.1472-8206.2006.00425.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"1459_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1472-8206.2011.00935.x","volume":"26","author":"J Becker","year":"2012","unstructured":"Becker J, Delayre-Orthez C, Frossard N, Pons F (2012) The peroxisome proliferator-activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung: fenofibrate and airway reactivity. Fundam Clin Pharmacol 26(3):340\u2013346. \nhttps:\/\/doi.org\/10.1111\/j.1472-8206.2011.00935.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"1459_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1476-5381.2009.00373.x","volume":"158","author":"MG Belvisi","year":"2009","unstructured":"Belvisi MG, Mitchell JA (2009) Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol 158(4):994\u20131003. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2009.00373.x","journal-title":"Br J Pharmacol"},{"issue":"7090","key":"1459_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235\u2013238. \nhttps:\/\/doi.org\/10.1038\/nature04753","journal-title":"Nature"},{"issue":"6","key":"1459_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-3083.2012.02686.x","volume":"75","author":"Y Bi","year":"2012","unstructured":"Bi Y, Yang R (2012) Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions: direct and indirect regulatory mechanisms in TH17 cell. Scand J Immunol 75(6):543\u2013552. \nhttps:\/\/doi.org\/10.1111\/j.1365-3083.2012.02686.x","journal-title":"Scand J Immunol"},{"issue":"4","key":"1459_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1164\/ajrccm.155.4.9105089","volume":"155","author":"PB Bolton","year":"1997","unstructured":"Bolton PB, Lefevre P, McDonald DM (1997) Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 155(4):1428\u20131435. \nhttps:\/\/doi.org\/10.1164\/ajrccm.155.4.9105089","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1459_CR10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW, Holgate S, Kerwin E, Chon Y, Feng JY, Lin J, Lin SL (2013) Randomized, double-blind, placebo-controlled study of brodalumab, a human anti\u2013IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 188(11):1294\u20131302. \nhttps:\/\/doi.org\/10.1164\/rccm.201212-2318OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1459_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1067\/mai.2003.1557","volume":"111","author":"J Chakir","year":"2003","unstructured":"Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-\u03b2, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111(6):1293\u20131298. \nhttps:\/\/doi.org\/10.1067\/mai.2003.1557","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1459_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5114\/ceji.2016.58817","volume":"1","author":"H Cheng","year":"2016","unstructured":"Cheng H, Xi Y, Chi X, Wu Y, Liu G (2016) Fenofibrate treatment of rats with experimental autoimmune myocarditis by alleviating Treg\/Th17 disorder. Cent Eur J Immunol 1(1):64\u201370. \nhttps:\/\/doi.org\/10.5114\/ceji.2016.58817","journal-title":"Cent Eur J Immunol"},{"issue":"301","key":"1459_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab3142","volume":"7","author":"DF Choy","year":"2015","unstructured":"Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, Jia G, Ohri CM, Doran E, Vannella KM, Butler CA, Hargadon B, Sciurba JC, Gieseck RL, Thompson RW, White S, Abbas AR, Jackman J, Wu LC, Egen JG, Heaney LG, Ramalingam TR, Arron JR, Wynn TA, Bradding P (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7(301):301ra129. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aab3142","journal-title":"Sci Transl Med"},{"issue":"4","key":"1459_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30(4):576\u2013587. \nhttps:\/\/doi.org\/10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"issue":"1-2","key":"1459_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2007.11.040","volume":"581","author":"C Delayre-Orthez","year":"2008","unstructured":"Delayre-Orthez C, Becker J, Auwerx J, Frossard N, Pons F (2008) Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. Eur J Pharmacol 581(1-2):177\u2013184. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2007.11.040","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1459_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-91","volume":"6","author":"C Delayre-Orthez","year":"2005","unstructured":"Delayre-Orthez C, Becker J, Guenon I, Lagente V, Auwerx J, Frossard N, Pons F (2005) PPAR\u03b1 downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res 6(1):91. \nhttps:\/\/doi.org\/10.1186\/1465-9921-6-91","journal-title":"Respir Res"},{"issue":"1","key":"1459_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ppul.20338","volume":"41","author":"GM Denning","year":"2006","unstructured":"Denning GM, Stoll LL (2006) Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease? Pediatr Pulmonol 41(1):23\u201334. \nhttps:\/\/doi.org\/10.1002\/ppul.20338","journal-title":"Pediatr Pulmonol"},{"key":"1459_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/726740","volume":"2014","author":"F Dong","year":"2014","unstructured":"Dong F, Wang C, Duan J, Zhang W, Xiang D, Li M (2014) Puerarin attenuates ovalbumin-induced lung inflammation and hemostatic unbalance in rat asthma model. Evid Based Complement Alternat Med 2014:1\u20139. \nhttps:\/\/doi.org\/10.1155\/2014\/726740","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"1459_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/02770900802610050","volume":"46","author":"L Dong","year":"2009","unstructured":"Dong L, Li H, Wang S, Li Y (2009) Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma Off J Assoc Care Asthma 46(3):229\u2013233. \nhttps:\/\/doi.org\/10.1080\/02770900802610050","journal-title":"J Asthma Off J Assoc Care Asthma"},{"key":"1459_CR20","doi-asserted-by":"publisher","unstructured":"Estrela GR, Wasinski F, Batista RO, Hiyane MI, Felizardo RJF, Cunha F, de Almeida DC, Malheiros DMAC, C\u00e2mara NOS, Barros CC, Bader M, Araujo RC (2017) Caloric restriction is more efficient than physical exercise to protect from cisplatin nephrotoxicity via PPAR-alpha activation. Front Physiol 8. \nhttps:\/\/doi.org\/10.3389\/fphys.2017.00116","DOI":"10.3389\/fphys.2017.00116"},{"issue":"6","key":"1459_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/0091-6749(91)90253-K","volume":"88","author":"W Elwood","year":"1991","unstructured":"Elwood W, L\u00f6tvall JO, Barnes PJ, Chung KF (1991) Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol 88(6):951\u2013960. \nhttps:\/\/doi.org\/10.1016\/0091-6749(91)90253-K","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1459_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11596-013-1144-5","volume":"33","author":"Y Guo","year":"2013","unstructured":"Guo Y, Huang H, Zeng D et al (2013) Interleukin (IL)-4 induces production of cytokine-induced neutrophil chemoattractants (CINCs) and intercellular adhesion molecule (ICAM)-1 in lungs of asthmatic rats. J Huazhong Univ Sci Technol Med Sci 33(4):470\u2013478. \nhttps:\/\/doi.org\/10.1007\/s11596-013-1144-5","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"8","key":"1459_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/sj.bjp.0704022","volume":"132","author":"EB Haddad","year":"2001","unstructured":"Haddad EB, Birrell M, McCluskie K, Ling A, Webber SE, Foster ML, Belvisi MG (2001) Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. Br J Pharmacol 132(8):1715\u20131724. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0704022","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1459_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1165\/rcmb.2010-0027TR","volume":"44","author":"R Halwani","year":"2011","unstructured":"Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q (2011) Role of transforming growth factor-\u03b2 in airway remodeling in asthma. Am J Respir Cell Mol Biol 44(2):127\u2013133. \nhttps:\/\/doi.org\/10.1165\/rcmb.2010-0027TR","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"1459_CR25","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","volume":"125","author":"AT Hastie","year":"2010","unstructured":"Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER, National Heart, Lung, and Blood Institute Severe Asthma Research Program (2010) Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 125(5):1028\u20131036.e13. \nhttps:\/\/doi.org\/10.1016\/j.jaci.2010.02.008","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1459_CR26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1164\/rccm.201309-1702ED","volume":"188","author":"YJ Huang","year":"2013","unstructured":"Huang YJ, Boushey HA (2013) The bronchial microbiome and asthma phenotypes. Am J Respir Crit Care Med 188(10):1178\u20131180. \nhttps:\/\/doi.org\/10.1164\/rccm.201309-1702ED","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1459_CR27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/BF02977330","volume":"30","author":"CH Jung","year":"2007","unstructured":"Jung CH, Lee JY, Cho CH, Kim CJ (2007) Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Arch Pharm Res 30(12):1599\u20131607. \nhttps:\/\/doi.org\/10.1007\/BF02977330","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1459_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.25011\/cim.v33i3.13726","volume":"33","author":"X Ke","year":"2010","unstructured":"Ke X, Huang J, Chen Q, Hong S, Zhu D (2010) Protective effects of combined Mycobacterium bovis BCG and interleukin-12 vaccination on airway inflammation in a murine model of allergic asthma. Clin Invest Med 33(3):196\u2013202. \nhttps:\/\/doi.org\/10.25011\/cim.v33i3.13726","journal-title":"Clin Invest Med"},{"issue":"10","key":"1459_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, FitzGerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology guidelines for management of gout Part I: Systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64(10):1431\u20131446. \nhttps:\/\/doi.org\/10.1002\/acr.21772","journal-title":"Arthritis Care Res"},{"issue":"1-3","key":"1459_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2012.11.033","volume":"701","author":"S-H Kim","year":"2013","unstructured":"Kim S-H, Hong J-H, Lee Y-C (2013) Ursolic acid, a potential PPAR\u03b3 agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. Eur J Pharmacol 701(1-3):131\u2013143. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2012.11.033","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1459_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/bcpt.12003","volume":"112","author":"R Krysiak","year":"2013","unstructured":"Krysiak R, Gdula-Dymek A, Okopien B (2013) The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol 112(3):198\u2013202. \nhttps:\/\/doi.org\/10.1111\/bcpt.12003","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"1459_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cyto.2015.07.022","volume":"76","author":"A Kumari","year":"2015","unstructured":"Kumari A, Dash D, Singh R (2015) Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. Cytokine 76(2):334\u2013342. \nhttps:\/\/doi.org\/10.1016\/j.cyto.2015.07.022","journal-title":"Cytokine"},{"issue":"25","key":"1459_CR33","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2174\/138161206778194169","volume":"12","author":"I Kurucz","year":"2006","unstructured":"Kurucz I, Szelenyi I (2006) Current animal models of bronchial asthma. Curr Pharm Des 12(25):3175\u20133194. \nhttps:\/\/doi.org\/10.2174\/138161206778194169","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1459_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","volume":"16","author":"BN Lambrecht","year":"2014","unstructured":"Lambrecht BN, Hammad H (2014) The immunology of asthma. Nat Immunol 16(1):45\u201356. \nhttps:\/\/doi.org\/10.1038\/ni.3049","journal-title":"Nat Immunol"},{"issue":"1","key":"1459_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2007.03.113","volume":"133","author":"JW Lee","year":"2007","unstructured":"Lee JW, Bajwa PJ, Carson MJ, Jeske DR, Cong Y, Elson CO, Lytle C, Straus DS (2007) Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133(1):108\u2013123. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2007.03.113","journal-title":"Gastroenterology"},{"issue":"7","key":"1459_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/labinvest.2010.78","volume":"90","author":"X-Z Li","year":"2010","unstructured":"Li X-Z, Feng J-T, C-P H et al (2010) Effects of Arkadia on airway remodeling through enhancing TGF-\u03b2 signaling in allergic rats. Lab Investig 90(7):997\u20131003. \nhttps:\/\/doi.org\/10.1038\/labinvest.2010.78","journal-title":"Lab Investig"},{"issue":"3","key":"1459_CR37","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc13-0790","volume":"37","author":"PE Linz","year":"2014","unstructured":"Linz PE, Lovato LC, Byington RP, O\u2019Connor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB (2014) Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid trial. Diabetes Care 37(3):686\u2013693. \nhttps:\/\/doi.org\/10.2337\/dc13-0790","journal-title":"Diabetes Care"},{"issue":"2","key":"1459_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1124\/jpet.117.241927","volume":"362","author":"APP Lowe","year":"2017","unstructured":"Lowe APP, Thomas RS, Nials AT, Kidd EJ, Broadley KJ, Ford WR (2017) Route of administration affects corticosteroid sensitivity of a combined ovalbumin and lipopolysaccharide model of asthma exacerbation in guinea pigs. J Pharmacol Exp Ther 362(2):327\u2013337. \nhttps:\/\/doi.org\/10.1124\/jpet.117.241927","journal-title":"J Pharmacol Exp Ther"},{"issue":"14","key":"1459_CR39","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","volume":"71","author":"K McKeage","year":"2011","unstructured":"McKeage K, Keating GM (2011) Fenofibrate: a review of its use in dyslipidaemia. Drugs 71(14):1917\u20131946. \nhttps:\/\/doi.org\/10.2165\/11208090-000000000-00000","journal-title":"Drugs"},{"issue":"11","key":"1459_CR40","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.4049\/jimmunol.1103176","volume":"188","author":"N Mizutani","year":"2012","unstructured":"Mizutani N, Goshima H, Nabe T, Yoshino S (2012) Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J Immunol 188(11):5694\u20135705. \nhttps:\/\/doi.org\/10.4049\/jimmunol.1103176","journal-title":"J Immunol"},{"issue":"3","key":"1459_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","volume":"110","author":"LA Moraes","year":"2006","unstructured":"Moraes LA, Piqueras L, Bishop-Bailey D (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110(3):371\u2013385. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2005.08.007","journal-title":"Pharmacol Ther"},{"key":"1459_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/609395","volume":"2013","author":"Y Morishima","year":"2013","unstructured":"Morishima Y, Ano S, Ishii Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Hizawa N (2013) Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma. Clin Dev Immunol 2013:1\u20139. \nhttps:\/\/doi.org\/10.1155\/2013\/609395","journal-title":"Clin Dev Immunol"},{"key":"1459_CR43","unstructured":"Muti A, Bolfa P, Muti L, Muresan A (2014) Vitamin E attenuates the degree of histopathological lung damage following toluene diisocyanate administration in rats"},{"issue":"4","key":"1459_CR44","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","volume":"29","author":"H Ogura","year":"2008","unstructured":"Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M, Nishihara M, Iwakura Y, Hirano T (2008) Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29(4):628\u2013636. \nhttps:\/\/doi.org\/10.1016\/j.immuni.2008.07.018","journal-title":"Immunity"},{"issue":"6","key":"1459_CR45","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms18061328","volume":"18","author":"\u00d3 Palomares","year":"2017","unstructured":"Palomares \u00d3, S\u00e1nchez-Ram\u00f3n S, D\u00e1vila I, Prieto L, P\u00e9rez de Llano L, Lleonart M, Domingo C, Nieto A (2017) How IgE axis contributes to the continuum of allergic asthma and anti-IgE therapies. Int J Mol Sci 18(6):1328. \nhttps:\/\/doi.org\/10.3390\/ijms18061328","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1459_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-78","volume":"11","author":"SJ Park","year":"2010","unstructured":"Park SJ, Lee YC (2010) Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res 11(1):78. \nhttps:\/\/doi.org\/10.1186\/1465-9921-11-78","journal-title":"Respir Res"},{"key":"1459_CR47","doi-asserted-by":"publisher","first-page":"PA4010","DOI":"10.1183\/13993003.congress-2015.PA4010","volume":"46","author":"M Rehnberg","year":"2015","unstructured":"Rehnberg M, Ramneg\u00e5rd M, Krutr\u00f6k N et al (2015) The role of lL-17 in the OVA-LPS driven model of lung inflammation. Eur Respir J 46:PA4010. \nhttps:\/\/doi.org\/10.1183\/13993003.congress-2015.PA4010","journal-title":"Eur Respir J"},{"issue":"2","key":"1459_CR48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cea.12880","volume":"47","author":"D Robinson","year":"2017","unstructured":"Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, Hanania NA, Nair P (2017) Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy 47(2):161\u2013175. \nhttps:\/\/doi.org\/10.1111\/cea.12880","journal-title":"Clin Exp Allergy"},{"issue":"1-3","key":"1459_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2012.05.026","volume":"689","author":"M Samah","year":"2012","unstructured":"Samah M, El-Aidy AE-R, Tawfik MK, Ewais MMS (2012) Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 689(1-3):186\u2013193. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2012.05.026","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1459_CR50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1165\/rcmb.2006-0084OC","volume":"35","author":"S Sharma","year":"2006","unstructured":"Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B (2006) Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-\u03b1 levels. Am J Respir Cell Mol Biol 35(4):488\u2013495. \nhttps:\/\/doi.org\/10.1165\/rcmb.2006-0084OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"1459_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/thx.2005.043695","volume":"60","author":"D Shoseyov","year":"2005","unstructured":"Shoseyov D (2005) Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A2. Thorax 60(9):747\u2013753. \nhttps:\/\/doi.org\/10.1136\/thx.2005.043695","journal-title":"Thorax"},{"issue":"6","key":"1459_CR52","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/jcp.22979","volume":"227","author":"JAF Silva","year":"2012","unstructured":"Silva JAF, Ferrucci DL, Peroni LA, Abrah\u00e3o PGS, Salamene AF, Rossa-Junior C, Carvalho HF, Stach-Machado DR (2012) Sequential IL-23 and IL-17 and increased Mmp8 and Mmp14 expression characterize the progression of an experimental model of periodontal disease in type 1 diabetes. J Cell Physiol 227(6):2441\u20132450. \nhttps:\/\/doi.org\/10.1002\/jcp.22979","journal-title":"J Cell Physiol"},{"issue":"1","key":"1459_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirol Carlton Vic 11(1):54\u201361. \nhttps:\/\/doi.org\/10.1111\/j.1440-1843.2006.00784.x","journal-title":"Respirol Carlton Vic"},{"issue":"1","key":"1459_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1710-1492-10-32","volume":"10","author":"A Singh","year":"2014","unstructured":"Singh A, Yamamoto M, Ruan J, Choi J, Gauvreau GM, Olek S, Hoffmueller U, Carlsten C, FitzGerald J, Boulet LP, O'Byrne PM, Tebbutt SJ (2014) Th17\/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response. Allergy Asthma Clin Immunol 10(1):32. \nhttps:\/\/doi.org\/10.1186\/1710-1492-10-32","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"1459_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/rr40","volume":"2","author":"JW Steinke","year":"2001","unstructured":"Steinke JW, Borish L (2001) Th2 cytokines and asthma\u2014interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2(2):66\u201370. \nhttps:\/\/doi.org\/10.1186\/rr40","journal-title":"Respir Res"},{"issue":"12","key":"1459_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s000110050642","volume":"49","author":"I Szelenyi","year":"2000","unstructured":"Szelenyi I (2000) Animal models of bronchial asthma. Inflamm Res Off J Eur Histamine Res Soc Al 49(12):639\u2013654. \nhttps:\/\/doi.org\/10.1007\/s000110050642","journal-title":"Inflamm Res Off J Eur Histamine Res Soc Al"},{"key":"1459_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/VHRM.S95044","volume":"Volume 13","author":"N Tarantino","year":"2017","unstructured":"Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, di Biase M, Brunetti ND (2017) Fenofibrate\/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy. Vasc Health Risk Manag Volume 13:29\u201341. \nhttps:\/\/doi.org\/10.2147\/VHRM.S95044","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"1459_CR58","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10875-012-9828-3","volume":"33","author":"A Vazquez-Tello","year":"2013","unstructured":"Vazquez-Tello A, Halwani R, Hamid Q, Al-Muhsen S (2013) Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells. J Clin Immunol 33(2):466\u2013478. \nhttps:\/\/doi.org\/10.1007\/s10875-012-9828-3","journal-title":"J Clin Immunol"},{"key":"1459_CR59","unstructured":"Wang L-P, Wang Y-W, Wang B-Z, et al (2014) Expression of interleukin-17A in lung tissues of irradiated mice and the influence of dexamethasone. In: Sci. World J. \nhttps:\/\/www.hindawi.com\/journals\/tswj\/2014\/251067\/\n\n. Accessed 15 Oct 2017"},{"issue":"5","key":"1459_CR60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11882-011-0210-y","volume":"11","author":"Y-H Wang","year":"2011","unstructured":"Wang Y-H, Wills-Karp M (2011) The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep 11(5):388\u2013394. \nhttps:\/\/doi.org\/10.1007\/s11882-011-0210-y","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1459-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T22:34:15Z","timestamp":1518561255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1459-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,30]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1459-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,30]]}}}